The Recall Desk
HighFDA (Food)·F-1523-2013·Announced 2013-06-19

XYMOGEN Artriphen Recalled for Undeclared Soy and Milk Allergens

XYMOGEN Artriphen joint supplement is being recalled because the label fails to declare soy and milk, posing a risk to allergic consumers.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall involves allergen mislabeling on common allergens (soy and milk), which corresponds to a High severity score per the rubric.

Plain-English summary

Atlantic Pro Nutrients, Inc. dba XYMOGEN is recalling 16,268 units of XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen, 90 and 180 capsule bottles. The recall is due to undeclared soy and milk on the product label.

The affected product was distributed in AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NJ, NM, NY, OH, OK, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, WY, District of Columbia, and Hawaii. All SKUs are included in this recall.

Consumers with allergies to soy or milk should not use this product. Individuals should check their inventory for this specific product and dispose of it or return it to the point of purchase.

The recalled product

Product
XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support Healthy Joint Function, 90 and 180 capsule bottles
Affected units
16,268

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All SKUs

Distribution

Same manufacturer · Atlantic Pro Nutrients, Inc. dba XYMOGEN

See all →